missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human FXYD6 (aa 61-90) Control Fragment Recombinant Protein
Click to view available options
Cantidad:
100 μL
Tamaño de la unidad:
100 microlitros
Descripción
Highest antigen sequence indentity to the following orthologs: Mouse (93%), Rat (93%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-65327 (PA5-65327. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a member of the FXYD family of transmembrane proteins. This particular protein encodes phosphohippolin, which likely affects the activity of Na,K-ATPase. Multiple alternatively spliced transcript variants encoding the same protein have been described. Related pseudogenes have been identified on chromosomes 10 and X. Read-through transcripts have been observed between this locus and the downstream sodium/potassium-transporting ATPase subunit gamma (FXYD2, GeneID 486) locus.

Especificaciones
Especificaciones
Número de acceso | Q9H0Q3 |
Concentración | ≥5.0 mg/mL |
Para utilizar con (aplicación) | Blocking Assay, Control |
Formulación | 1 M urea, PBS with no preservative; pH 7.4 |
ID de gen (Entrez) | 53826 |
Nombre | Human FXYD6 (aa 61-90) Control Fragment |
Cantidad | 100 μL |
Estado normativo | RUO |
Alias de gen | 0610030I18Rik; FXYD domain containing ion transport regulator 6; FXYD domain-containing ion transport regulator 6; Fxyd6; Phosphohippolin; Php; PLM-like protein; Plp; UNQ521/PRO1056; Vascular endothelial cell-specific protein 6; VESP6 |
Nombre común | FXYD6 |
Mostrar más |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
Invitrogen™ Human FXYD6 (aa 61-90) Control Fragment Recombinant Protein >
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido